Study, Evaluating Pharmacokinetics, Pharmacodynamics, Immunogenicity and Safety Profiles of Rituximab Compared to MabThera ® in Patients With Rheumatoid Arthritis

Conditions: Rheumatoid Arthritis Interventions: Drug: Rituximab; Drug: MabThera ® Sponsors: Mabscale, LLC Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials